STOCK TITAN

Prestige Consmr Healthcare Inc Stock Price, News & Analysis

PBH NYSE

Welcome to our dedicated page for Prestige Consmr Healthcare news (Ticker: PBH), a resource for investors and traders seeking the latest updates and insights on Prestige Consmr Healthcare stock.

The PBH news page on Stock Titan tracks announcements and disclosures from Prestige Consumer Healthcare Inc., a consumer healthcare products company listed on the New York Stock Exchange. Prestige issues frequent press releases covering its over-the-counter (OTC) brand portfolio, financial performance and corporate activities across the U.S. and Canada, Australia, and certain other international markets.

Investors and observers can use this news feed to follow quarterly and annual earnings releases, where Prestige reports revenues, net income, earnings per share, free cash flow, leverage and segment results for its North American OTC Healthcare and International OTC Healthcare businesses. These updates often highlight category trends such as gastrointestinal, women’s health, cough and cold, and eye and ear care, as well as the performance of brands including Monistat®, Summer’s Eve®, Clear Eyes®, Dramamine®, Fleet®, Hydralyte® and others.

The PBH news stream also includes announcements about investor conference participation, such as presentations at consumer staples and consumer growth and e-commerce conferences, and notices of upcoming earnings calls with webcast details. Corporate actions and regulatory topics appear as well, including the voluntary recall by Medtech Products Inc., a Prestige company, of specific lots of Little Remedies® Honey Cough Syrup due to microbial contamination, and communications about strategic transactions like the planned acquisition of Pillar5 Pharma Inc., a sterile ophthalmic manufacturer and Clear Eyes® supplier.

By reviewing the PBH news page regularly, readers can see how Prestige describes its business priorities, category performance, capital allocation decisions such as share repurchases, and developments affecting its OTC healthcare brands and supply chain.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.57%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.83%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.53%
Tags
conferences
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.94%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.24%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.05%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.79%
Tags
conferences
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.58%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.22%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.26%
Tags

FAQ

What is the current stock price of Prestige Consmr Healthcare (PBH)?

The current stock price of Prestige Consmr Healthcare (PBH) is $55.56 as of April 8, 2026.

What is the market cap of Prestige Consmr Healthcare (PBH)?

The market cap of Prestige Consmr Healthcare (PBH) is approximately 2.6B.